Overview

Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

This is an open-label, randomized, multicenter, 2-way crossover study in subjects 12 years or older with perennial allergic rhinitis (PAR) to evaluate the psychometric properties of a novel-patient administered assessment of treatment satisfaction with and preference of an Internasal Corticosteroid (INCS)

Phase:

Phase 3

Details

Lead Sponsor:

Sunovion

Treatments:

Ciclesonide
Mometasone Furoate